Unexplained weight loss (UWL), defined as a loss of 5% or more of total body weight within a 6-12 month period without a clear cause, oftentimes presents a diagnostic challenge in clinical practice. This article seeks to provide a comprehensive approach to the assessment and management of this condition.
The etiology of UWL is vast, ranging from malignancies, gastrointestinal disorders, endocrine abnormalities, psychiatric conditions, to infectious diseases. Malignancies, especially gastrointestinal and lung cancers, have been identified as the most common cause. However, no cause is found in up to 25% of cases, even after extensive evaluation.
A thorough history and physical examination should be the initial step in the evaluation of UWL. This should be followed by basic laboratory tests and imaging studies based on the suspected underlying cause. If these initial investigations are inconclusive, more specialized tests and referrals may be necessary. It is also crucial to consider the patient's age, as the risk of malignancy increases with age.
The management of UWL primarily involves treating the underlying cause. In cases where no cause is identified, the focus should be on nutritional support and close monitoring of the patient. Behavioral interventions may also be beneficial. In addition, patients should be reassured that a significant proportion of UWL cases remain idiopathic and are not associated with serious illness.
In conclusion, UWL is a complex condition that requires a systematic and patient-centered approach. While it can be a sign of serious underlying disease, it is important to remember that a significant proportion of cases remain unexplained. The primary goal should be to provide supportive care and reassurance to the patient while continuing to monitor for potential causes.
1.
Primary Sjögren's syndrome patients' B-Cell Stimulating Factors are associated with the growth of lymphomas.
2.
Long-Acting Interferon Therapy Approved for ET
3.
More cancer cases in areas where incarceration rates are high: Study
4.
Firefighters who eat better can combat cancer.
5.
Second opinions don't significantly delay breast cancer treatment
1.
New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma
2.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
3.
Unlocking the Potential of Plinabulin: A New Frontier in Cancer Treatment
4.
Deep Learning Fluorescence Imaging for Oral Cancer Surgery: In Silico Depth Quantification
5.
Regenerative Reprogramming of Dormant Cellular Niches Following Cancer Therapy
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Hands-on Workshop: Hematology
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
4.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation